Ignite Creation Date:
2024-05-05 @ 9:08 PM
Last Modification Date:
2024-10-26 @ 9:59 AM
Study NCT ID:
NCT00810017
Status:
TERMINATED
Last Update Posted:
2022-05-19
First Post:
2008-12-16
Brief Title:
Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer
Sponsor:
Medstar Health Research Institute
Organization:
Medstar Health Research Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-02
Start Date Type:
None
Primary Completion Date:
2010-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-06
Completion Date Type:
ACTUAL
First Submit Date:
2008-12-16
First Submit QC Date:
December 16 2008
Study First Post Date:
2008-12-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2022-05-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-27
Last Update Post Date:
2022-05-19
Last Update Post Date Type:
ACTUAL